123 Pill - pink oval, 20mm
Generic Name: efavirenz/emtricitabine/tenofovir disoproxil
Pill with imprint 123 is Pink, Oval and has been identified as Atripla efavirenz 600mg / emtricitabine 200mg / tenofovir disoproxil fumarate 300mg. It is supplied by Gilead Sciences, Inc.
Atripla is used in the treatment of HIV Infection; Nonoccupational Exposure; Occupational Exposure and belongs to the drug class antiviral combinations. There is positive evidence of human fetal risk during pregnancy. Atripla efavirenz 600mg / emtricitabine 200mg / tenofovir disoproxil fumarate 300mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 123



Atripla
- Generic Name
- efavirenz/emtricitabine/tenofovir disoproxil
- Imprint
- 123
- Strength
- efavirenz 600mg / emtricitabine 200mg / tenofovir disoproxil fumarate 300mg
- Color
- Pink
- Size
- 20.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Antiviral combinations
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Gilead Sciences, Inc.
- Inactive Ingredients
-
croscarmellose sodium,
magnesium stearate,
microcrystalline cellulose,
sodium lauryl sulfate,
ferrosoferric oxide,
polyethylene glycol 3350,
ferric oxide red,
magnesium silicate,
titanium dioxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
15584-0101 (Discontinued) | |
35356-0064 (Discontinued) | Lake Erie Medical and Surgical Supply (repackager) |
54569-5805 (Discontinued) | A-S Medication Solutions, LLC (repackager) |
54868-5643 | Physicians Total Care Inc. (repackager) |
Related images for "123"
More about Atripla (efavirenz / emtricitabine / tenofovir disoproxil)
- Check interactions
- Compare alternatives
- Reviews (105)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: antiviral combinations
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.